Raed A. Dweik, MD, MBA, ATSF, elected in 2023, serves as the President.
Dr. Dweik currently holds the E. Tom and Erica Meyer Endowed Professorship and serves as chair of Pulmonary and Critical Care Medicine and enterprise chief of the Integrated Hospital Care Institute - IHI (Pulmonary, Critical Care, Infectious Disease, Emergency Services, Urgent and Express Care, Anesthesiology, Hospital Medicine, Perioperative Medicine) at Cleveland Clinic Health System. Dr. Dweik joined the ATS in 1994 and is a member of the Pulmonary Circulation Assembly.1
Michelle Ng Gong, MD, MS, ATSF elected in 2024, serves as the President-Elect. Dr. Gong will serve as President in 2026-2027.
Dr. Gong is Professor of Medicine and Professor of Epidemiology and Population Health at Albert Einstein College of Medicine. She is the Chief of the Divisions of Pulmonary Medicine and Chief of Critical Care Medicine, and director of Critical Care Research at Montefiore Medical Center. Dr. Gong joined the ATS in 1998 and is a member of the Critical Care Assembly.2
Jesse Roman, MD, ATSF, elected in 2025, serves as the Secretary. Dr. Roman will serve as President in 2027-2028.
Dr. Roman is the Ludwig Kind Professor of Medicine and enterprise division chief, Pulmonary, Allergy and Critical Care Medicine at Thomas Jefferson University in Philadelphia. He also serves as CEO of the Jane & Leonard Korman Respiratory Institute of Jefferson Health and National Jewish Health. Dr. Roman conducts NIH-sponsored research in lung tissue remodeling and is involved in clinical trials. He joined the ATS in 1988 and is a member of the Respiratory Cell & Molecular Biology Assembly.3
Irina Petrache, MD, ATSF, elected in 2021, serves as the Immediate Past-President.
Dr. Petrache is professor of medicine at National Jewish Health and at the University of Colorado. She also serves as chief of Pulmonary, Critical Care and Sleep Medicine, associate vice president of Faculty Development, and Wollowick Chair in COPD Research at National Jewish Health. Dr. Petrache joined the ATS in 1997 and is a member of the Respiratory Cell & Molecular Biology Assembly.4
Gregory Tino, MD, ATSF, FCCP, FACP, elected in 2024, serves as the Treasurer, 2025-2028.
Dr. Tino is Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He is Chief of the Department of Medicine at Penn Presbyterian Medical Center and Senior Vice Chair of the Department of Medicine at the University of Pennsylvania. He joined the ATS in 1991 and is a member of the Clinical Problems Assembly.5
Karen J. Collishaw, MPP, CAE, appointed as Chief Executive Officer in May 2018.
Prior to joining the ATS, Ms. Collishaw was the president & CEO of the Community Health Accreditation Program, an independent, not-for-profit accrediting body for community-based health care organizations. Previously, Ms. Collishaw served in executive leadership positions with two professional medical societies--the American Academy of Dermatology and the American College of Cardiology. She was responsible for activities related to science, research, advocacy, quality, and managed the ACC’s annual scientific session.
Following the completion of a Bachelor of Arts in Government from Cornell University, Ms. Collishaw started her career working for the U.S. House of Representatives and then in Battelle Memorial Institute’s Washington office. She earned a Master of Public Policy degree from Georgetown University, is a certified association executive, and past president of the American Association of Medical Society Executives.
- 2025 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Dweik is an investigator and inventor on a Joint Development and Option agreement between the Cleveland Clinic and BreathTech Corporation, a wholly owned subsidiary of Astrotech Corporation. The aim of the research project is to develop a rapid breath test for coronavirus infection or related indicators. Dr. Dweik is entitled to commercialization revenues as an inventor of the intellectual property. back to text
- 2025 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: She served as a scientific advisor for Novartis Pharma for the ARDS trial. She serves as a scientific advisor for Regeneron Pharmaceuticals on the sepsis trial. She serves on the data safety and monitoring board for clinical trials on protein intake, implementation of ABCDE bundle, and sepsis treatment in critically ill patients. She serves as a section editor for UpToDate. back to text
- 2025 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Roman received industry-sponsored research support for clinical trials from Boehringer Ingelheim, Brystol-Myers Squibb, United Therapeutics. He served on a DSMB for Boehringer Ingelheim, evaluating safety of interventions. back to text
- 2025 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Petrache is a scientific co-founder of Allinaire Therapeutics, which develops novel therapeutics for pulmonary arterial hypertension and other pulmonary diseases, including EMAP II. She conducted research supported by Allinaire, which evolved from her work with colleagues as part of the University of Indiana Center for Biomedical Innovation and is funded by Biomotiv. She also served as a consultant for Ceramedix for antibody therapies and participated in National Institutes of Health-supported research on sphingolipids and the effect of vaping on lung parenchyma. back to text
- 2025 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Tino received research support from the COPD Foundation on behalf of the University of Pennsylvania by serving as principal investigator for bronchiectasis and NTM research registry. He serves on an advisory board for Boehringer Ingelheim and receives no financial reimbursement for services provided. back to text